Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi 75271, Pakistan.
Department of Medicine, Mayo Hospital Lahore, King Edward Medical University Lahore, Lahore 54000, Pakistan.
Viruses. 2022 Sep 6;14(9):1972. doi: 10.3390/v14091972.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) has been a rising concern since its declaration as a pandemic by the World Health Organization on 11 March 2020. Recently, its association with multiple underlying organs has been identified that includes cardiac, renal, gastrointestinal, nervous systems, and cutaneous manifestations. Cutaneous COVID-19 findings have been supposedly classified into the following categories: vesicular (varicella-like), papulo-vesiculsar, chilblains-like ("COVID toes") maculopapular, and urticarial morphologies. In this review, we aim to focus on the proposed pathophysiology behind the various dermatological manifestations associated with COVID-19 and their associated management. We also included prevalence and clinical features of the different COVID-19-related skin lesions in our review. A comprehensive narrative review of the literature was performed in PubMed databases. Data from case reports, observational studies, case series, and reviews till June 2022 were all screened and included in the review.
自 2020 年 3 月 11 日世界卫生组织宣布新冠病毒大流行以来,严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)一直受到关注。最近,人们已经确定它与多个潜在器官有关,包括心脏、肾脏、胃肠道、神经系统和皮肤表现。COVID-19 的皮肤表现据称可分为以下几类:水疱(水痘样)、丘疹水疱样、冻疮样(“COVID 脚趾”)、斑丘疹和荨麻疹样形态。在这篇综述中,我们旨在关注与 COVID-19 相关的各种皮肤表现背后的提议病理生理学及其相关管理。我们还在综述中纳入了不同 COVID-19 相关皮肤损伤的患病率和临床特征。我们在 PubMed 数据库中进行了全面的文献叙述性综述。筛选并纳入了截至 2022 年 6 月的病例报告、观察性研究、病例系列和综述中的数据。